Concept

Neurogranin

OpenAlex ID: C2780748493

Biomarkers for Alzheimer's disease: current status and prospects for the future

2018 · K. Blennow, H. Zetterberg · Journal of Internal Medicine · 1,046

PDF

Current state of Alzheimer’s fluid biomarkers

2018 · José Luis Molinuevo, Scott Ayton, et al. · Acta Neuropathologica · 543

PDF

Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease

2016 · Edward J. Goetzl, Dimitrios Kapogiannis, et al. · The FASEB Journal · 402

Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile

2016 · Charisse N. Winston, Edward J. Goetzl, et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 388

PDF

Transcript profiling of human platelets using microarray and serial analysis of gene expression

2003 · Dmitri V. Gnatenko, John J. Dunn, et al. · Blood · 372

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease

2019 · Sebastian Palmqvist, Philip S Insel, et al. · EMBO Molecular Medicine · 360

The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease

2020 · the Synaptic Health Endpoints Working Group, Martí Colom-Cadena, et al. · Alzheimer s Research & Therapy · 349

PDF

Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease

2014 · Hlin Kvartsberg, Flora H. Duits, et al. · Alzheimer s & Dementia · 348

Reasons for Failed Trials of Disease-Modifying Treatments for Alzheimer Disease and Their Contribution in Recent Research

2019 · Konstantina G. Yiannopoulou, Aikaterini I. Anastasiou, et al. · Biomedicines · 335

PDF

A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood

2017 · Kaj Blennow · Neurology and Therapy · 303

PDF

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

2016 · Niklas Mattsson, Philip S Insel, et al. · EMBO Molecular Medicine · 301

Abnormality of m6A mRNA Methylation Is Involved in Alzheimer’s Disease

2020 · Min Han, Zhen Liu, et al. · Frontiers in Neuroscience · 288

PDF

Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer’s disease

2015 · Erik Portelius, Henrik Zetterberg, et al. · Brain · 288

Neurogranin: immunocytochemical localization of a brain-specific protein kinase C substrate

1990 · A Represa, JC Deloulme, et al. · Journal of Neuroscience · 277

PDF

Involvement of neurogranin in the modulation of calcium/calmodulin-dependent protein kinase II, synaptic plasticity, and spatial learning: A study with knockout mice

2000 · Jhang Ho Pak, Freesia L. Huang, et al. · Proceedings of the National Academy of Sciences · 273

Purification and characterization of a brain-specific protein kinase C substrate, neurogranin (p17). Identification of a consensus amino acid sequence between neurogranin and neuromodulin (GAP43) that corresponds to the protein kinase C phosphorylation site and the calmodulin-binding domain.

1991 · J Baudier, J C Deloulme, et al. · Journal of Biological Chemistry · 273

Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer’s Disease

2021 · Chun-Hung Chang, Chieh-Hsin Lin, et al. · International Journal of Molecular Sciences · 265

PDF

Mechanism of protein kinase C activation during the induction and maintenance of long-term potentiation probed using a selective peptide substrate.

1993 · E Klann, S J Chen, et al. · Proceedings of the National Academy of Sciences · 261

Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease

2015 · Maartje I. Kester, Charlotte E. Teunissen, et al. · JAMA Neurology · 249

PDF

Blood neuro‐exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stage

2020 · Longfei Jia, Min Zhu, et al. · Alzheimer s & Dementia · 247

Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum

2020 · Marta Milà‐Alomà, Gemma Salvadó, et al. · Alzheimer s & Dementia · 247

PDF

Poor sleep is associated with CSF biomarkers of amyloid pathology in cognitively normal adults

2017 · Kate E. Sprecher, Rebecca L. Koscik, et al. · Neurology · 235

PDF

Increased CSF neurogranin concentration is specific to Alzheimer disease

2016 · Henrietta Wellington, Ross W. Paterson, et al. · Neurology · 234

PDF

Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease

2016 · Rawan Tarawneh, Gina D’Angelo, et al. · JAMA Neurology · 225

PDF

Regulation of Synaptic Plasticity Genes during Consolidation of Fear Conditioning

2002 · Kerry J. Ressler, Gayla Paschall, et al. · Journal of Neuroscience · 218

PDF

Works count: 1,129

Citation count: 27,950